Hagley, United Kingdom

Kenneth G Cooper


Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • West Midlands, GB (1991)
  • Hagley, GB (1988 - 1998)

Company Filing History:


Years Active: 1988-1998

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Kenneth G. Cooper: Innovator in Biocidal Technologies**

Introduction

Kenneth G. Cooper is a distinguished inventor based in Hagley, GB, recognized for his significant contributions to the field of biocidal technology. With a total of five patents to his name, he demonstrates a strong commitment to innovation and excellence in his work.

Latest Patents

Among Kenneth’s latest patents is a biocidal mixture of tetrakis (hydroxymethyl) phosphonium salt, which showcases his innovative approach to enhancing biocidal activity. This invention highlights how the activity of THP (tetrakis hydroxymethyl phosphonium) compounds is synergistically improved when used in conjunction with wetting agents. In addition, his work on biocidal compositions illustrates the synergistic effects of phosphonium salts, such as THP, and aldehydes like formaldehyde, which exhibit enhanced biocidal properties.

Career Highlights

Kenneth G. Cooper is associated with Albright & Wilson Limited, a company that specializes in various chemical solutions, including biocidal products. His inventive prowess within the realm of biocides has allowed him to progress in his career and establish a reputation as a leading innovator in his field.

Collaborations

Throughout his career, Kenneth has collaborated with notable colleagues such as Robert E. Talbot and Malcolm J. Turvey. These partnerships have further fueled his creative endeavors, resulting in significant advancements in biocidal technologies.

Conclusion

Kenneth G. Cooper's work is a testament to the impact of innovative thinking in the biocidal technology sector. With his ongoing contributions and advancements, he continues to play a vital role in developing solutions that enhance efficacy in biocidal applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…